Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Йордан ДИМИТРОВ, Чавдар РУМЕНИН, Чавдар ВАСИЛЕВfiledCriticalЙордан ДИМИТРОВ
Priority to BG108223ApriorityCriticalpatent/BG65588B1/en
Publication of BG108223ApublicationCriticalpatent/BG108223A/en
Publication of BG65588B1publicationCriticalpatent/BG65588B1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Peptides Or Proteins
(AREA)
Abstract
The method is applied in the fractionizing of human blood proteins for medical purposes. It considerably increases the autoreactivity of human plasma. By the method liquid immunoglobulin is placed in a device generating permanent homogenous magnetic field, the increase of which, until reaching its end value, continues for no less than 1 min. The time of the magnetic field effect on the preparation is no less than 5 min. The immunoglobulin preparation undergoes a stage of self-stabilization for no less than 10 min, after which it is practically applicable during the entire life of its effectiveness.
BG108223A2003-10-032003-10-03Method for the alteration of the autoreactivity of liquid immunoglobulin preparations
BG65588B1
(en)
Neutralising, a high-affinity anti-TNF-alpha isolated human antibody, use of this antibody, crystal containing the anti-TNF-alpha human antibody and a preparation containing the crystal
COMBINED METHOD OF MEDICAL IMPACT, INCLUDING THE APPLICATION OF RADIATION THERAPY AND CYCLOOXYGENASE-2 (COX-2) INHIBITOR FOR THE TREATMENT OF NEOPLASIA